MNPR icon

Monopar Therapeutics
MNPR

Overview Fund Activity

42 hedge funds and large institutions have $113M invested in Monopar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 11 closing their positions.

Holders
42
Holders Change
+7
Holders Change %
+20%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
15
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$7.34M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$3.47M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$41.6M
4
ABG
4
Ally Bridge Group
New York
$1.24M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.09M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$3.72M
2
Millennium Management
2
Millennium Management
New York
$529K
3
Marshall Wace
3
Marshall Wace
United Kingdom
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$0
5
Jane Street
5
Jane Street
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
– – -303 Closed
PD
52
Point72 (DIFC)
United Arab Emirates
– – -196 Closed
FDCDDQ
53
Federation des caisses Desjardins du Quebec
Quebec, Canada
– – -16 Closed
1 2
3